|Category:||Advanced Biotech Company Presentation|
|Speaker:||Dr. Michael Thompson|
DyNAbind is a German biotech company offering drug discovery partnerships leveraging its proprietary platform of DNA-Encoded Library technologies. By combining both small molecule and fragment-based approaches with an unrivaled level of quality control and a deep in-house informatics pipeline, DyNAbind offers a faster path to more relevant medicinal chemistry starting points. DyNAbind’s flexible, risk-minimized project schemes make sense for even the most challenging targets.